NCT07684534
Effect of the Ultrasound-guided Percutaneous Neuromodulation on the Mean Velocity in Crossfit Practitioners.
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
Version history last read from ClinicalTrials.gov on Aug 30, 2026. The record was updated there on Nov 20, 2026; versions filed since then are not listed here yet.
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Minor Enrollment closed, study ongoing
- Primary completion date changed from estimate of Oct 1, 2026 to Nov 16, 2026
- Notable Recruitment opened
- Start date changed from estimate of Jul 1, 2026 to Jul 8, 2026
- Secondary endpoints: details revised at 1 of 4 entries
- Site details revised
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (4)
Arms and interventions
The patients will receive ultrasound-guided percutaneous neuromodulation of the iliohypogastric and ilioinguinal nerves using electrical stimulation at 10 Hz in 10-second cycles.
The patients will receive a sham ultrasound-guided percutaneous neuromodulation procedure involving identical needle insertion under ultrasound guidance without electrical stimulation
Other: ultrasound-guided percutaneous neuromodulation, ultrasound-guided percutaneous neuromodulation (sham)
Sites
1 site in 1 country
- Fisiosport premium SLMurcia, Murcia, Spain